In vivo therapeutic efficacy of TNFα silencing by folate-PEG-chitosan-DEAE/siRNA nanoparticles in arthritic mice

Código QR

In vivo therapeutic efficacy of TNFα silencing by folate-PEG-chitosan-DEAE/siRNA nanoparticles in arthritic mice

Qin Shi,1 Elsa-Patricia Rondon-Cavanzo,1 Isadora Pfeifer Dalla Picola,1,2 Marcio José Tiera,2 Xiaoling Zhang,3 Kerong Dai,4 Houda Abir Benabdoune,1 Mohamed Benderdour,1 Julio Cesar Fernandes1 1Orthopedic Research Laboratory, Hôpital du Sacré-Coeur de Montr&eacute...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Shi Q, Rondon-Cavanzo EP, Dalla Picola IP, Tiera MJ, Zhang X, Dai K, Benabdoune HA, Benderdour M, Fernandes JC
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2018
Materias:	Arthritis inflammation siRNA TNF nanoparticles chitosan Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/0ed5d0f8ff0647bf9579a1c2b8c44ea4
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Silencing tumor necrosis factor-alpha in vitro from small interfering RNA-decorated titanium nanotube array can facilitate osteogenic differentiation of mesenchymal stem cells
por: Wang Z, et al.
Publicado: (2016)

Lyophilization and stability of antibody-conjugated mesoporous silica nanoparticle with cationic polymer and PEG for siRNA delivery
por: Ngamcherdtrakul W, et al.
Publicado: (2018)

Nucleic Acid-Based Treatments Against COVID-19: Potential Efficacy of Aptamers and siRNAs
por: Javad Khanali, et al.
Publicado: (2021)

The therapeutic effect in gliomas of nanobubbles carrying siRNA combined with ultrasound-targeted destruction
por: Cai W, et al.
Publicado: (2018)

Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes
por: Jin M, et al.
Publicado: (2018)

Liposomal codelivery of an SN38 prodrug and a survivin siRNA for tumor therapy
por: Bi Y, et al.
Publicado: (2018)

Small interfering RNAs (siRNAs) in cancer therapy: a nano-based approach
por: Mahmoodi Chalbatani G, et al.
Publicado: (2019)

Nanoscale polysaccharide derivative as an AEG-1 siRNA carrier for effective osteosarcoma therapy
por: Wang F, et al.
Publicado: (2018)

Evidence Supporting the Safety of Pegylated Diethylaminoethyl-Chitosan Polymer as a Nanovector for Gene Therapy Applications
por: Rondon EP, et al.
Publicado: (2020)

Targeting cell cycle protein in gastric cancer with CDC20siRNA and anticancer drugs (doxorubicin and quercetin) co-loaded cationic PEGylated nanoniosomes
por: Hemati M, et al.
Publicado: (2019)

A Lipid-Coated Nanoconstruct Composed of Gold Nanoparticles Noncovalently Coated with Small Interfering RNA: Preparation, Purification and Characterization
por: Anna V. Epanchintseva, et al.
Publicado: (2021)

Effect of the nanoformulation of siRNA-lipid assemblies on their cellular uptake and immune stimulation
por: Kubota K, et al.
Publicado: (2017)

Novel functionalized nanoparticles for tumor-targeting co-delivery of doxorubicin and siRNA to enhance cancer therapy
por: Xia Y, et al.
Publicado: (2017)

Antitumor effect of hyaluronic-acid-modified chitosan nanoparticles loaded with siRNA for targeted therapy for non-small cell lung cancer
por: Zhang W, et al.
Publicado: (2019)

Quick synthesis of a novel combinatorial delivery system of siRNA and doxorubicin for a synergistic anticancer effect
por: Chen M, et al.
Publicado: (2019)

Multifunctional selenium nanoparticles as carriers of HSP70 siRNA to induce apoptosis of HepG2 cells
por: Li Y, et al.
Publicado: (2016)

GE11 peptide-conjugated nanoliposomes to enhance the combinational therapeutic efficacy of docetaxel and siRNA in laryngeal cancers
por: Xu WW, et al.
Publicado: (2017)

pH-responsive hybrid nanoparticle with enhanced dissociation characteristic for siRNA delivery
por: Shi M, et al.
Publicado: (2018)

Enhancing siRNA-based cancer therapy using a new pH-responsive activatable cell-penetrating peptide-modified liposomal system
por: Xiang B, et al.
Publicado: (2017)

Hypoxia-responsive ionizable liposome delivery siRNA for glioma therapy
por: Liu HM, et al.
Publicado: (2017)

Simultaneous silencing of VEGF and KSP by siRNA cocktail inhibits proliferation and induces apoptosis of hepatocellular carcinoma Hep3B cells
por: Doan,Chung Chinh, et al.
Publicado: (2014)

Efficient delivery of Notch1 siRNA to SKOV3 cells by cationic cholesterol derivative-based liposome
por: Zhao Y, et al.
Publicado: (2016)

Superparamagnetic iron oxide nanoparticles modified with polyethylenimine and galactose for siRNA targeted delivery in hepatocellular carcinoma therapy
por: Yang Z, et al.
Publicado: (2018)

Tumor-specific delivery of therapeutic siRNAs by anti-EGFR immunonanoparticles
por: Kim JS, et al.
Publicado: (2018)

Integrin-β1, not integrin-β5, mediates osteoblastic differentiation and ECM formation promoted by mechanical tensile strain
por: Zeng,Qiangcheng, et al.
Publicado: (2015)

Effects of c-FLIPL Knockdown in Cervical Uterine Carcinoma Cell Lines
por: Ili,Carmen G, et al.
Publicado: (2015)

VEGF siRNA delivered by polycation liposome-encapsulated calcium phosphate nanoparticles for tumor angiogenesis inhibition in breast cancer
por: Chen J, et al.
Publicado: (2017)

Reductive nanocomplex encapsulation of cRGD-siRNA conjugates for enhanced targeting to cancer cells
por: Zhou Z, et al.
Publicado: (2017)

siRNA-loaded selenium nanoparticle modified with hyaluronic acid for enhanced hepatocellular carcinoma therapy
por: Xia Y, et al.
Publicado: (2018)

Doxorubicin and anti-VEGF siRNA co-delivery via nano-graphene oxide for enhanced cancer therapy in vitro and in vivo
por: Sun Q, et al.
Publicado: (2018)

Gene-silencing effects of anti-survivin siRNA delivered by RGDV-functionalized nanodiamond carrier in the breast carcinoma cell line MCF-7
por: Bi YZ, et al.
Publicado: (2016)

Lipid nanoparticles for targeted siRNA delivery – going from bench to bedside
por: Zatsepin TS, et al.
Publicado: (2016)

Codelivery of temozolomide and siRNA with polymeric nanocarrier for effective glioma treatment
por: Peng Y, et al.
Publicado: (2018)

Anti-EpCAM functionalized graphene oxide vector for tumor targeted siRNA delivery and cancer therapy
por: Si Chen, et al.
Publicado: (2021)

Hyaluronic acid reagent functional chitosan-PEI conjugate with AQP2-siRNA suppressed endometriotic lesion formation
por: Zhao MD, et al.
Publicado: (2016)

Cyclic Peptide-Gadolinium Nanocomplexes as siRNA Delivery Tools
por: Amir Nasrolahi Shirazi, et al.
Publicado: (2021)

Highly efficient siRNA transfection in macrophages using apoptotic body-mimic Ca-PS lipopolyplex
por: Lai Y, et al.
Publicado: (2018)

Polyethylene glycol–poly(ε-benzyloxycarbonyl-L-lysine)-conjugated VEGF siRNA for antiangiogenic gene therapy in hepatocellular carcinoma
por: Wang GM, et al.
Publicado: (2017)

Arrowtail RNA for Ligand Display on Ginger Exosome-like Nanovesicles to Systemic Deliver siRNA for Cancer Suppression
por: Zhefeng Li, et al.
Publicado: (2018)

Inhibition of cell proliferation through an ATP-responsive co-delivery system of doxorubicin and Bcl-2 siRNA
por: Zhang J, et al.
Publicado: (2017)